Idioma:

BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination

Chen, Fan ; Yan, Qinying ; Yu, Yang ; Wu, Mei X.

Journal of controlled release, 2017-06, Vol.255, p.36-44 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por

Enviar para

Título:
BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination
Autor: Chen, Fan ; Yan, Qinying ; Yu, Yang ; Wu, Mei X.
Assuntos: Animals ; Antibodies, Bacterial - immunology ; BCG powder ; BCG Vaccine - administration & dosage ; BCG Vaccine - pharmacology ; Cytokines - immunology ; Female ; Immunoglobulin G - immunology ; Injections, Intradermal ; Injections, Subcutaneous ; Lesion-free ; Lung - drug effects ; Lung - immunology ; Lymphocytes - drug effects ; Lymphocytes - immunology ; Male ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Microinjections ; Microneedles ; Needles ; Powders ; Skin - drug effects ; Skin - pathology ; Skin delivery ; Spleen - drug effects ; Spleen - immunology ; Vaccination - instrumentation ; Vaccination - methods
É parte de: Journal of controlled release, 2017-06, Vol.255, p.36-44
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Live attenuated Bacille Calmette–Guerin (BCG) bacillus is the only licensed vaccine for tuberculosis prevention worldwide to date. It must be delivered intradermally to be effective, which causes severe skin inflammation and sometimes, permanent scars. To minimize the side effects, we developed a novel microneedle array (MNA) that could deliver live attenuated freeze-dried BCG powder into the epidermis in a painless, lesion-free, and self-applicable fashion. The MNA was fabricated with biocompatible and dissolvable hyaluronic acid with a deep cave formed in the basal portion of each microneedle, into which BCG powder could be packaged directly. Viability of BCG vaccine packaged in the caves and the mechanical strength of the powder-laden MNA did not alter significantly before and after more than two months of storage at room temperature. Following insertion of the MNA into the skin, individual microneedle shafts melted away by interstitial fluid from the epidermis and upper dermis, exposing the powder to epidermal tissues. The powder sucked interstitial fluid, dissolved slowly, and diffused into the epidermis in a day against the interstitial fluid influx. Vaccination with BCG-MNA caused no overt skin irritation, in marked contrast to intradermal vaccination that provoked severe inflammation and bruise. While causing little skin irritation, vaccination efficacy of BCG-MNAs was comparable to that of intradermal immunization whether it was evaluated by humoral or cellular immunity. This powder-laden and dissolvable MNA represents a novel technology to sufficiently deliver live attenuated vaccine powders into the skin.
Editor: Netherlands: Elsevier B.V
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 9 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination

Chen, Fan ; Yan, Qinying ; Yu, Yang ; Wu, Mei X.

Netherlands: Elsevier B.V

Buscando em bases de dados remotas. Favor aguardar.